Global Hydronephrosis Market: Latest Trends, Opportunities and Driver
According to a new report published by Reports Monitor titled, “Global Hydronephrosis Market, Growth Opportunities, Innovations and Forecast,2018-2025,” the Hydronephrosis Market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2018 to 2025.
Hydronephrosis is a swelling of the kidney due to inability of urine to drain in bladder. Symptoms of this condition is depend on the severity of the disease weather it is acute or progressive. Increasing kidney diseases raise incidence of hydronephrosis and boost the growth of the market.
Availability of advanced diagnosis techniques and treatment fuels the market. Increasing geriatric population can be driving the growth of the market. diagnosis of intermittent hydronephrosis is a challenge as mild degree of dilation observe in imaging studies. This market is gaining demand as developing healthcare infrastructure supports the growth of the market.
This report provides a detailed analysis of hydronephrosis market, which includes current industry situations such as market size, growth and demands, market outlook, major players with their key strategies such as investment, mergers and acquisitions, value chain analysis and porter’s analysis. It covers the market canvas and the growth opportunities in the coming years. The report has been made with an in-depth analysis along with important inputs from the various industry experts. The research is carried out with both extensive primary and secondary data sources supported with either bottom up or top down approach.
The global hydronephrosis market is segmented on the basis of diagnosis, treatmet and indication. On the basis of diagnosis, the market is segmented into laboratory test and imaging. On the basis of treatment, the market is segmented into laparoscopy, wave lithotripsy, bladder catheterization, steroid therapy and others. On the basis of indication, the market is segmented into intrinsic and extrinsic.
The global hydronephrosis market is majorly studied across four regions: North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa). Availability of new technology, awareness of disease and increased geriatric population drives the growth of the market. Rising population, developing healthcare infrastructure and increasing disposal income attributes the growth in Asia-Pacific region.
The major key players operating in the market are: Novartis AG, EDAP TMS, Inceler Medikal Co. Ltd., Tenko Corporation Group, SILMAG, Smiths Medical, TROGE MEDICAL GmbH, GAMA GROUP, a.s., UROTECH, C. R. Bard, Inc. , Boston Scientific Corporation, NephroGenex, Inc., American Renal Associates, Phraxis, Inc., Renal Associates P.A., ALLERGAN, Amgen Inc., Anthem Bio Pharm and Sanofi.
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.